• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提取和验证用于丰富化合物库的亚结构谱。

Extraction and validation of substructure profiles for enriching compound libraries.

机构信息

Novartis Institute for Tropical Diseases, Chromos, Singapore, Singapore.

出版信息

J Comput Aided Mol Des. 2012 Oct;26(10):1127-41. doi: 10.1007/s10822-012-9604-8. Epub 2012 Sep 16.

DOI:10.1007/s10822-012-9604-8
PMID:22983491
Abstract

Compounds known to be potent against a specific protein target may potentially contain a signature profile of common substructures that is highly correlated to their potency. These substructure profiles may be useful in enriching compound libraries or for prioritizing compounds against a specific protein target. With this objective in mind, a set of compounds with known potency against six selected kinases (2 each from 3 kinase families) was used to generate binary molecular fingerprints. Each fingerprint key represents a substructure that is found within a compound and the frequency with which the fingerprint occurs was then tabulated. Thereafter, a frequent pattern mining technique was applied with the aim of uncovering substructures that are not only well represented among known potent inhibitors but are also unrepresented among known inactive compounds and vice versa. Substructure profiles that are representative of potent inhibitors against each of the 3 kinase families were thus extracted. Based on our validation results, these substructure profiles demonstrated significant enrichment for highly potent compounds against their respective kinase targets. The advantages of using our approach over conventional methods in analyzing such datasets and its application in the mining of substructures for enriching compound libraries are presented.

摘要

针对特定蛋白质靶标的化合物,如果已知其具有很强的抑制作用,那么这些化合物可能具有共同的特征结构,这些特征结构与它们的抑制活性高度相关。这些结构特征可以用于丰富化合物库,或者用于针对特定蛋白质靶标对化合物进行优先级排序。基于这一目标,使用了一组针对六种选定激酶(每个激酶家族各两种)具有已知抑制活性的化合物来生成二元分子指纹。每个指纹键代表一个在化合物中发现的结构,然后统计指纹出现的频率。然后,应用频繁模式挖掘技术,旨在发现不仅在已知有效抑制剂中很好地表示,而且在已知非活性化合物中也没有表示的结构。因此,提取了针对每个激酶家族的有效抑制剂的代表性结构特征。基于我们的验证结果,这些结构特征在针对各自激酶靶标的高活性化合物中表现出显著的富集。本文还介绍了与传统方法相比,使用这种方法分析此类数据集的优势,以及在丰富化合物库方面挖掘结构特征的应用。

相似文献

1
Extraction and validation of substructure profiles for enriching compound libraries.提取和验证用于丰富化合物库的亚结构谱。
J Comput Aided Mol Des. 2012 Oct;26(10):1127-41. doi: 10.1007/s10822-012-9604-8. Epub 2012 Sep 16.
2
Substructural Connectivity Fingerprint and Extreme Entropy Machines-A New Method of Compound Representation and Analysis.亚结构连接指纹与极端熵机器:一种新的化合物表示与分析方法。
Molecules. 2018 May 23;23(6):1242. doi: 10.3390/molecules23061242.
3
Substructure mining using elaborate chemical representation.使用精细化学表示法的子结构挖掘
J Chem Inf Model. 2006 Mar-Apr;46(2):597-605. doi: 10.1021/ci0503715.
4
Protocols for the Design of Kinase-focused Compound Libraries.激酶靶向化合物库设计方案
Mol Inform. 2018 May;37(5):e1700119. doi: 10.1002/minf.201700119. Epub 2017 Nov 8.
5
Mapping Biological Activities to Different Types of Molecular Scaffolds: Exemplary Application to Protein Kinase Inhibitors.将生物活性映射到不同类型的分子支架:蛋白激酶抑制剂的示例应用
Methods Mol Biol. 2018;1825:327-337. doi: 10.1007/978-1-4939-8639-2_10.
6
Fragment-based approaches to the discovery of kinase inhibitors.基于片段的激酶抑制剂发现方法。
Methods Enzymol. 2014;548:69-92. doi: 10.1016/B978-0-12-397918-6.00003-3.
7
Enriching screening libraries with bioactive fragment space.用生物活性片段空间丰富筛选文库。
Bioorg Med Chem Lett. 2016 Aug 1;26(15):3594-7. doi: 10.1016/j.bmcl.2016.06.013. Epub 2016 Jun 7.
8
Conserved core substructures in the overlay of protein-ligand complexes.蛋白质-配体复合物叠层中的保守核心亚结构。
J Chem Inf Model. 2011 Aug 22;51(8):1931-41. doi: 10.1021/ci100475y. Epub 2011 Jul 22.
9
Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches.激酶抑制剂数据建模与基于片段方法的全新抑制剂设计
J Med Chem. 2009 Oct 22;52(20):6456-66. doi: 10.1021/jm901147e.
10
Design of chemical libraries with potentially bioactive molecules applying a maximum common substructure concept.应用最大公共子结构概念设计具有潜在生物活性的分子的化学文库。
Mol Divers. 2010 May;14(2):401-8. doi: 10.1007/s11030-009-9187-z. Epub 2009 Aug 15.

引用本文的文献

1
Machine learning in chemoinformatics and drug discovery.机器学习在化学生信学和药物发现中的应用。
Drug Discov Today. 2018 Aug;23(8):1538-1546. doi: 10.1016/j.drudis.2018.05.010. Epub 2018 May 8.

本文引用的文献

1
Computational Modeling of Kinase Inhibitor Selectivity.激酶抑制剂选择性的计算建模
ACS Med Chem Lett. 2010 Jul 28;1(8):395-9. doi: 10.1021/ml1001097. eCollection 2010 Nov 11.
2
Interrogating the kinome.探究激酶组。
Nat Biotechnol. 2011 Nov 8;29(11):981-3. doi: 10.1038/nbt.2021.
3
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.综合激酶催化活性分析揭示激酶抑制剂选择性特征。
Nat Biotechnol. 2011 Oct 30;29(11):1039-45. doi: 10.1038/nbt.2017.
4
ChEMBL: a large-scale bioactivity database for drug discovery.ChEMBL:用于药物发现的大型生物活性数据库。
Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7. doi: 10.1093/nar/gkr777. Epub 2011 Sep 23.
5
Selectivity of kinase inhibitor fragments.激酶抑制剂片段的选择性。
J Med Chem. 2011 Jul 28;54(14):5131-43. doi: 10.1021/jm200349b. Epub 2011 Jun 23.
6
Akt1 and Akt2: differentiating the aktion.Akt1 和 Akt2:区分作用。
Histol Histopathol. 2011 May;26(5):651-62. doi: 10.14670/HH-26.651.
7
PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints.PaDEL-descriptor:一个开源软件,可用于计算分子描述符和指纹。
J Comput Chem. 2011 May;32(7):1466-74. doi: 10.1002/jcc.21707. Epub 2010 Dec 17.
8
Drug discovery and the human kinome: recent trends.药物发现与人类蛋白质组学:最新趋势。
Pharmacol Ther. 2011 May;130(2):144-56. doi: 10.1016/j.pharmthera.2011.01.007. Epub 2011 Jan 20.
9
PubChem as a public resource for drug discovery.PubChem 作为一个公共的药物发现资源。
Drug Discov Today. 2010 Dec;15(23-24):1052-7. doi: 10.1016/j.drudis.2010.10.003. Epub 2010 Oct 21.
10
Selectively nonselective kinase inhibition: striking the right balance.选择性非选择性激酶抑制:把握恰当平衡。
J Med Chem. 2010 Feb 25;53(4):1413-37. doi: 10.1021/jm901132v.